The Isothermal Nucleic Acid Amplification Technology Market Size is valued at USD 4.8 Bn in 2024 and is predicted to reach USD 12.0 Bn by the year 2034 at a 9.7% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
The Isothermal Nucleic Acid Amplification Technology (INAAT) is seeing a significant increase in demand as a molecular testing technique, owing mostly to the increasing prevalence of infectious diseases. Infectious diseases such as hepatitis, influenza, and others are among the main causes of death, particularly in underdeveloped nations. As a result, the demand for quick, easy-to-use, disease-specific testing alternatives is predicted to drive up the adoption of INAAT solutions.
Rapid advancements in existing amplification technologies, as well as the development of technologies such as Single Primer Isothermal Amplification, Loop-Mediated Isothermal Amplification, Recombinase Polymerase Amplification, and others, are paving the way for new INAAT product applications. For example, in June 2022, a research study published in the Analyst Journal demonstrated the creation of smartphone-integrated equipment that can rapidly test for the Zika virus in a single blood drop utilizing LAMP technology. Such advancements are likely to increase the technique's commercial penetration shortly.
The INAAT market has been divided based on product, technology, application, and end-user. The market is segmented as assays and systems based on product. The technology segment includes TMA, LAMP, SDA, NASBA, SPIA, NEAR, and HDA. The application segment includes diagnosis, blood screening, and other applications. As per the end-users, the market is bifurcated into hospitals, reference laboratories, academic & research laboratories, and other end-users.
The highest market share was held by loop-mediated isothermal amplification (LAMP). The method allows for several detection modes, such as real-time fluorescence using intercalators, lateral flow, and agarose gel detection. As a result, the approach can detect a wide spectrum of RNA and DNA targets in human samples, including the Zika virus and SARS-CoV-2 virus. Furthermore, the technique's resistance to inhibitors allows it to be used with crude samples and little processed nucleic acids, which increasesdemand.
The hospital segment dominated the market. This is due to the introduction of miniaturized point-of-care INAAT equipment that allows for single-level access for hospital-based analysis. Similarly, the increased throughput and automation provided by such technologies for the processing of a high number of samples are likely to drive market expansion.
North America dominated the market due to the region's existing research infrastructure and rising demand for nucleic acid amplification-based diagnostics for infectious disease prevention. Furthermore, high per capita healthcare spending and a growing emphasis on point-of-care diagnostic methods are expected to boost market expansion.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 4.8 Bn |
| Revenue Forecast In 2034 | USD 12.0 Bn |
| Growth Rate CAGR | CAGR of 9.7% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, Technology, Application, End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioMérieux SA (France), Tecan Trading AG (Switzerland), New England Biolabs (US), QIAGEN N.V. (Germany), DiaSorin Sp.A. (Italy), General Electric (US), OptiGene Limited (UK), Quidel Corporation (US), Thermo Fisher Scientific (US). Genomtec (Poland), Mast Group Ltd. (UK), Ustar Biotechnologies (China), Jena Bioscience GmbH (Germany), Atila BioSystems (US), TwistDx Limited (UK), LGC Limited (UK), Life Sciences Advanced Technologies (US), GenoSensor Corporation (US), and PCR Biosystems (UK). |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Isothermal Nucleic Acid Amplification Technology Market Snapshot
Chapter 4. Global Isothermal Nucleic Acid Amplification Technology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product:
5.2.1. Assays, Kits, & Reagents
5.2.2. Systems
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Product & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
6.2.1. Disease Diagnosis
6.2.1.1. Hepatitis
6.2.1.2. Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)
6.2.1.3. Influenza
6.2.1.4. Covid-19
6.2.1.5. Other Disease Diagnosis
6.2.2. Blood Screening
6.2.3. Other Applications
Chapter 7. Market Segmentation 3: By Technology Estimates & Trend Analysis
7.1. By Product & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Technology:
7.2.1. Transcription Mediated Amplification (TMA)
7.2.2. Loop-mediated Isothermal Amplification (LAMP)
7.2.3. Strand Displacement Amplification (SDA)
7.2.4. Helicase-dependent Amplification (HDA)
7.2.5. Nucleic Acid Sequence-based Amplification (NASBA)
7.2.6. Nicking Enzyme Amplification Reaction (NEAR)
7.2.7. Single Primer Isothermal Amplification (SPIA)
7.2.8. Other Technologies
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By Product & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
8.2.1. Hospitals
8.2.2. Reference Laboratories
8.2.3. Academic & Research Institutes
8.2.4. Other End Users
Chapter 9. Isothermal Nucleic Acid Amplification Technology Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.1.2. North America Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.1.3. North America Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.1.4. North America Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By, End User 2021-2034
9.1.5. North America Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.2.2. Europe Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.2.3. Europe Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.2.4. Europe Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By End User ,2021-2034
9.2.5. Europe Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By country, 2021-2034
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.3.2. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.3.3. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.3.4. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.3.5. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.4.2. Latin America Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.4.3. Latin America Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.4.4. Latin America Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.4.5. Latin America Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By country, 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.5.2. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.5.3. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.5.4. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.5.5. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market revenue (US$ Million) estimates and forecasts By country, 2021-2034
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Hologic, Inc.
10.2.2. Abbott Laboratories
10.2.3. Grifols, S.A.
10.2.4. Becton, Dickinson And Company
10.2.5. Meridian Bioscience
10.2.6. Eiken Chemical Co., Ltd.
10.2.7. Quidel Corporation
10.2.8. Qiagen N.V.
10.2.9. New England Biolabs
10.2.10. Diasorin S.P.A.
10.2.11. Biomérieux Sa
10.2.12. Tecan Trading Group
10.2.13. General Electric Company
10.2.14. Thermo Fisher Scientific
10.2.15. Optigene Limited
10.2.16. Other Companies
Isothermal Nucleic Acid Amplification Technology Market By Product-
Isothermal Nucleic Acid Amplification Technology Market By Technology-
Isothermal Nucleic Acid Amplification Technology Market By Application-
By End-User-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-